Structural Formula (Cymbalta 01)
Cymbalta
Product Images NDC 52959-892
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Cymbalta (NDC 52959-892). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by H.j. Harkins Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Cymbalta 02)
Figure 2 (Cymbalta 03)
Figure 3 (Cymbalta 13)
Figure 4 (Cymbalta 14)
Figure 5 (Cymbalta 15)
This text displays a chart that shows the percentage of improvement in pain from baseline for patients using either a placebo or CYM60/120 mg once daily. The horizontal axis shows the percentage improvement in pain, while the vertical axis shows the percentage of patients. It appears that more patients who took the medication experienced improvement in their pain compared to those who took the placebo.*
Figure 6 (Cymbalta 16)
The text describes a chart or graph displaying the percentage of patients who show improvement while being treated with a placebo versus a medication called CYMB0. The percent improvement in pain from baseline (BOCF) is also shown on the same chart. The chart displays 10 data points on the x-axis ranging from 210 to 250 and 10 data points on the y-axis ranging from 0 to 100.*
Figure 7 (Cymbalta 17)
The text indicates a graph displaying the percentage of patients who have improved, with data points labeled from 0 to 100 on the X-axis and percentage values from 0 to 100 on the Y-axis. The graph compares the performance of a placebo against a medication called CYMB0/120 mg taken once daily. The medication improves patients more than placebo across all percentage values, exceeding placebo by at least 10% at every point. The graph provides additional information on percent improvement in pain from Baseline (BOCF), but no data is available on this.*
Package Label- Cymbalta 60 mg, Bottle Of 30 (Cymbalta 60mg Contain 30 T1930)
This is a caution notice for a medication named CYMBALTA 60mg DR. Capsule manufactured by ELI-LILLY. The lot number is CYA76EL and the expiration date is 04/12. It is recommended to take the medication as directed by a doctor and to refer to the insert for usual dosage information. The medication is available as a green and blue opaque capsule with the pill identification imprint of CYATEEL.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
